Joan C. Egrie
Amgen (United States)(US)
Publications by Year
Research Areas
Erythropoietin and Anemia Treatment, Iron Metabolism and Disorders, Erythrocyte Function and Pathophysiology, Blood transfusion and management, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin(1987)2,019 cited
- → The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin(1998)1,923 cited
- → Cloning and expression of the human erythropoietin gene.(1985)1,146 cited
- → Recombinant Human Erythropoietin in Anemic Patients with End-Stage Renal Disease(1989)807 cited
- → Efficiency of signalling through cytokine receptors depends critically on receptor orientation(1998)553 cited
- → Development and characterization of novel erythropoiesis stimulating protein (NESP)(2001)511 cited
- → Enhancement of therapeutic protein in vivo activities through glycoengineering(2003)511 cited
- → Pharmacokinetics of Novel Erythropoiesis Stimulating Protein Compared with Epoetin Alfa in Dialysis Patients(1999)434 cited
- → Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin(2003)416 cited